XML 25 R8.htm IDEA: XBRL DOCUMENT
v3.19.1

GOING CONCERN | 12 Months Ended
--- | ---
Dec. 31, 2018
Going Concern [Abstract] |
GOING CONCERN | NOTE 2 – GOING CONCERN As of December 31, 2018, the Company had an accumulated deficit of $13,597,868 and experienced losses since its inception. Losses have principally occurred as a result of the substantial resources required for research and development of the Company’s products which included the general and administrative expenses associated with its organization and product development as well as the lack of sources of revenues until such time as the Company’s products are commercialized. These factors raise substantial doubt about the Company’s ability to continue as a going concern. These financial statements do not include any adjustments to reflect the possible future effect on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the outcome of these uncertainties. Management plans to seek additional funding through the issuance of common stock for cash and by implementing its strategic plan to develop its pharmaceutical products and allow the opportunity for the Company to continue as a going concern, however there cannot be any assurance that we will be successful in doing so. The Company raised net proceeds of approximately $7.2 in February 2019, received $0.6 million in grants in March 2019 and expects to receive an additional $0.4 million in grants on or prior to the first quarter of 2020, which the Company estimates should meet its planned operating requirements into the first quarter of 2020. The Company plans to raise additional capital to meet its future operating requirements until such time as the Company develops a recurring source of revenues, which is not expected for several years. The amount and timing of these capital raises is subject to general market conditions. There are no guarantees that the company will be able to complete these capital raises.

X
- References No definition available. + Details
Name: | inmb_GoingConcernAbstract
Namespace Prefix: | inmb_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of accounting policy for going concern. + References No definition available. + Details
Name: | inmb_GoingConcernTextBlock
Namespace Prefix: | inmb_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration